Natus Medical Incorporated Sustainability Profile
Natus Medical Incorporated, commonly referred to as Natus, is a leading provider of medical devices and services headquartered in the United States. Founded in 1989, the company has established a strong presence in the neurodiagnostic, newborn care, and hearing screening sectors, serving healthcare professionals across North America and globally. Natus is renowned for its innovative products, including advanced neurodiagnostic systems, neonatal monitoring solutions, and audiology equipment, which are designed to enhance patient care and improve clinical outcomes. The company’s commitment to quality and technological advancement has positioned it as a trusted partner in the medical community. With a focus on delivering exceptional value, Natus has achieved significant milestones, including numerous industry awards and recognitions, solidifying its status as a key player in the medical technology landscape.
DitchCarbon Score
How does Natus Medical Incorporated's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Natus Medical Incorporated's score of 25 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Natus Medical Incorporated's reported carbon emissions
In 2022, Natus Medical Incorporated reported total carbon emissions of approximately 686,600 kg CO2e, comprising 404,000 kg CO2e from Scope 1 and 282,600 kg CO2e from Scope 2 emissions. This data reflects a significant reduction from 2021, when the company emitted about 533,000,000 kg CO2e solely from Scope 1 emissions. Natus Medical has not disclosed any Scope 3 emissions data, nor have they set specific reduction targets or initiatives under the Science Based Targets initiative (SBTi). The absence of documented reduction targets suggests that while the company is aware of its emissions, it has yet to formalise a comprehensive climate commitment strategy. As a US-based organisation, Natus Medical's emissions data is not cascaded from any parent company, indicating that the figures are independently reported. The company continues to navigate the evolving landscape of corporate climate responsibility, with opportunities for future commitments to enhance its sustainability profile.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 533,000,000 | 000,000 |
| Scope 2 | - | 000,000 |
| Scope 3 | - | - |
How Carbon Intensive is Natus Medical Incorporated's Industry?
How Carbon Intensive is Natus Medical Incorporated's Location?
Natus Medical Incorporated's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Natus Medical Incorporated has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
